2019
DOI: 10.17219/dmp/108632
|View full text |Cite
|
Sign up to set email alerts
|

Low-level laser therapy (LLLT) in the treatment of recurrent aphthous stomatitis (RAS) – a promising treatment option: A report of two cases

Abstract: Recurrent aphthous stomatitis (RAS) is a chronic, ulcerative condition of the oral mucosa that affects 10-25% of the population. The etiopathogenesis of the disease is not fully understood, although a polygenic mode of inheritance and immunological dysregulation have been suggested in several studies. The contribution of numerous predisposing factors, such as a deficiency of iron, vitamin B12 or folic acid, trauma, emotional stress, endocrine disturbances, or allergy, have also been considered. So far, no caus… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 19 publications
0
4
0
Order By: Relevance
“…PBM limits the production of proinflammatory mediators, including tumor necrosis factor-α (TNF-α), Interleukin-1 (IL-1), IL-1β, and IL-6 in damaged neurons, inhibits prostaglandins E2 and increases the production of plasminogen, as well as stimulates post-traumatic maturation and regeneration. 19,22,[26][27][28] In addition, PBM can increase tissue microcirculation/oxygenation and stimulate the growth of epithelial, endothelial, and mesenchymal cells. 29 Enhanced tissue microcirculation can lead to an increase in the delivery of nutritional substances related to the elevated mitosis rate, resulting in neoangiogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…PBM limits the production of proinflammatory mediators, including tumor necrosis factor-α (TNF-α), Interleukin-1 (IL-1), IL-1β, and IL-6 in damaged neurons, inhibits prostaglandins E2 and increases the production of plasminogen, as well as stimulates post-traumatic maturation and regeneration. 19,22,[26][27][28] In addition, PBM can increase tissue microcirculation/oxygenation and stimulate the growth of epithelial, endothelial, and mesenchymal cells. 29 Enhanced tissue microcirculation can lead to an increase in the delivery of nutritional substances related to the elevated mitosis rate, resulting in neoangiogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…La estomatitis aftosa recurrente (RAS), corresponde a una de las lesiones orales más frecuentes [1][2][3] . Se define como una enfermedad inflamatoria crónica, dolorosa, caracterizada por lesión levemente eritematosa con una úlcera central cubierta por una membrana fibrinopurulenta (coloración blanquecino-amarillenta) de rápida resolutividad (2 a 3 semanas) que se localizan principalmente en la mucosa oral y lengua 4 . Dentro de ellas las aftas mayores son menos comúnes que las menores o herpetiformes y afectan tanto mucosa queratinizada como no-queratinizada, causando dolor y disfagia, lesiones de más de 10 mm de diámetro, más profundas, y que a menudo generan cicatrices, pudiendo permanecer de 2 semanas a 3 meses 3 .…”
Section: Introductionunclassified
“…AS comes in three forms, which are morphologically classified as minor aphtha or Mikulicz-ulcers, which show a diameter of 2-10 mm, major aphtha, also called mucosal necrotic periadenitis or Sutton ulcers (>10 mm in diameter), and herpetiform ulcerations, which consist of multiple small ulcers [4]. No causal treatment for RAS has been developed so far; systemic and topical medications are used to reduce inflammation and pain and to support the natural period of remission [5]. Management of oral ulcers is based on the severity of the lesions and usually involves the administration of corticosteroids [5].…”
Section: Introductionmentioning
confidence: 99%
“…No causal treatment for RAS has been developed so far; systemic and topical medications are used to reduce inflammation and pain and to support the natural period of remission [5]. Management of oral ulcers is based on the severity of the lesions and usually involves the administration of corticosteroids [5]. However, there is a lack of high-efficacy evidence for them [6], particularly for systemic interventions.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation